Rep. Sydney Kamlager-Dove votes against SAVE-Act

Rep. Sydney Kamlager-Dove (CA-37)
Rep. Sydney Kamlager-Dove (CA-37)
0Comments

The U.S. House voting record shows 208 Representatives voted against the Safeguard American Voter Eligibility Act, among them was Rep. Sydney Kamlager-Dove, who represents California’s 37th congressional district.

The SAVE Act (H.R.22) would require applicants to provide documentary proof of U.S. citizenship to register to vote in federal elections. It would bar states from accepting a federal registration form without that proof. Supporters argue it strengthens election integrity by ensuring only U.S. citizens can register for federal elections and standardizes enforcement.

On April 10, 2025, the U.S. House held Roll Call Vote 102 on final passage of H.R.22 (SAVE Act). The measure passed 220–208 in a recorded Yea-and-Nay vote, with 5 not voting. The party breakdown was Republicans: 216 yea, 0 nay, 4 not voting; Democrats: 4 yea, 208 nay, 1 not voting. The Clerk’s roll call preserves the official member-by-member positions tied to this final-passage action.

The SAVE Act would amend the National Voter Registration Act of 1993 and defines “documentary proof” of U.S. citizenship for federal voter registration. The bill also directs states to take steps to prevent noncitizens from being registered for federal elections, including procedures for identifying and removing ineligible registrants, as described in Congress.gov’s bill summary and text.

The U.S. House is one of Congress’s two chambers and part of the legislative branch. The number of voting Representatives is fixed by law at no more than 435, with members elected to two-year terms from congressional districts apportioned by population. The House introduces and votes on legislation and conducts committee work central to federal lawmaking.



Related

Dr. Mehmet Oz CMS Administrator

Medicaid payments for National Codes Established category in Torrance climb 8.5% in 2024

Medicaid expenditures attributed to the National Codes Established for State Medicaid Agencies category increased by 8.5% in Torrance in 2024, signaling shifts in service use and reimbursement.

Sridhar Mantha, Acting Chief Information Officer of FDA

FDA cites Masterpiece JP, Inc. in Torrance with 5 violations after March 17 inspection

Masterpiece JP, Inc. in Torrance was inspected by the FDA on March 17 for foodborne biological hazards and received five violations.

Sara Brenner, Principal Deputy Commissioner at FDA

FDA conducts March 17 inspection of Masterpiece JP, Inc. in Torrance

Masterpiece JP, Inc. in Torrance underwent an FDA inspection for foodborne biological hazards on March 17, based on information from the FDA’s website.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from South Bay Leader.